BioScrip Inc. (BIOS)
-NasdaqGS 8.58 
0.09(1.04%) 4:00PM EDT|After Hours
:
8.58 0.00 (0.00%) 5:34PM EDT
| Prev Close: | 8.67 |
|---|
| Open: | 8.56 |
|---|
| Bid: | 8.31 x 200 |
|---|
| Ask: | 8.78 x 4000 |
|---|
| 1y Target Est: | 11.43 |
|---|
| Beta: | 0.76 |
|---|
| Next Earnings Date: | 4-Nov-13 |
|---|
| Day's Range: | 8.51 - 8.61 |
|---|
| 52wk Range: | 8.29 - 17.62 |
|---|
| Volume: | 1,326,265 |
|---|
| Avg Vol (3m): | 1,299,150 |
|---|
| Market Cap: | 581.54M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.37 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against BioScrip, Inc. (NASDAQ: BIOS)Marketwired(Wed 4:01PM EDT)
- Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against BioScrip, Inc.Business Wire(Wed 11:14AM EDT)
- The BioScrip Inc. (BIOS) Moving Average Crossover SpottedZacks(Wed 2:54AM EDT)
- BIOSCRIP SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against BioScrip Inc. - BIOSMarketwired(Tue, Oct 1)
- SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $75,000 in Losses From Investment in BioScrip, Inc. to Contact Brower Piven Before the November 29, 2013 Lead Plaintiff DeadlineGlobeNewswire(Tue, Oct 1)
- Infusing a Fragmented Marketat Motley Fool(Tue, Oct 1)
- Robbins Arroyo LLP Is Investigating the Officers and Directors of BioScrip Inc. on Behalf of ShareholdersPR Newswire(Tue, Oct 1)
- Pomerantz Law Firm Has Filed a Class Action Against BioScrip, Inc. and Certain Officers -- BIOSGlobeNewswire(Mon, Sep 30)
- Wall Street Analysts’ Top Stocks to Buy Trading Under $1024/7 Wall St.(Mon, Sep 30)
- 3 Horrendous Health-Care Stocks This Weekat Motley Fool(Sat, Sep 28)
- Glancy Binkow & Goldberg LLP Announces Investigation on Behalf of Shareholders of BioScrip, Inc.Business Wire(Fri, Sep 27)
- Trade-Ideas: BioScrip (BIOS) Is Today's "Dead Cat Bounce" Stockat TheStreet(Wed, Sep 25)
- [video] 3 undervalued small capsat CNBC(Wed, Sep 25)
- Harwood Feffer LLP Announces Investigation of BioScrip, Inc.PR Newswire(Tue, Sep 24)
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioScrip, Inc. - BIOSPR Newswire(Mon, Sep 23)
Key Statistics
| Forward P/E (1 yr): | 24.51 |
|---|
| P/S (ttm): | 0.79 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.20 |
|---|
| Quarterly EPS Est
(Sep-13)
: | 0.03 |
|---|
| Mean Recommendation*: | 1.3 |
|---|
| PEG Ratio (5 yr expected): | 2.74 |
|---|
Business Summary
BioScrip, Inc. provides home infusion and other home care services, and pharmacy benefit management (PBM) services in the United States. It operates in three segments: Infusion Services, Home Health Services, and PBM Services.
View More